Krystal Biotech Inc

Krystal Biotech Executives Split: CEO and R&D Head Dump $6 M+ Shares Amid Quiet EVP Hold‑On, Raising Investor Speculation on Future Outlook

Krystal Biotech insider sales: CEO and R&D head sell millions of shares, while EVP holds—what does this mean for KRBS stock volatility and investor confidence?

Krystal Biotech Inc
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

07/03/2026, 00:42

6 minutes to read

Krystal Biotech COO Buys 12,500 Shares at $63 – A Bold Insider Bet on Gene‑Therapy Growth.

Krystal Biotech insider buying at $63.55 shows long‑term confidence amid FDA RMAT approval and volatile market, hinting at potential upside for investors.

Krystal Biotech Inc
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

12/02/2026, 01:24

4 minutes to read